Skip to main content

Glutathione (GSH) vs MOTS-c

Both Glutathione (GSH) and MOTS-c are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.

Glutathione (GSH)

Evidence B

Reduced L-Glutathione

Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.

View full Glutathione (GSH) profile →

MOTS-c

Evidence B

Mitochondrial-derived peptide MOTS-c

A 16-amino-acid mitochondrial-derived peptide that improves insulin sensitivity and exercise capacity in animal models. Among the most promising 'mitokines' for metabolic aging.

View full MOTS-c profile →

Side-by-Side

AttributeGlutathione (GSH)MOTS-c
Evidence GradeBB
FDA StatusNot FDA-approved as therapeutic — sold as supplement; intravenous use compoundedNot FDA-approved — research peptide; multiple early-phase clinical trials
Typical Dose200–600 mg sublingual / 600–2400 mg IV (compounded)5–10 mg, 2–3 times weekly (subcutaneous)
Clinics Indexed31222
Categoriesantioxidant, longevitymetabolic, longevity

Key reported benefits — Glutathione (GSH)

  • Master antioxidant
  • Liver detoxification support
  • Oxidative stress reduction

Key reported benefits — MOTS-c

  • Insulin sensitivity
  • Exercise capacity
  • Metabolic flexibility

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons